Oncology Biostatistics & Evidence Synthesis Services

Oncology Biostatistics

Bayesian adaptive designs, BOIN dose optimization, and seamless Phase I/II trials for cancer therapeutics. From solid tumor dose escalation to hematologic malignancy registration studies. Statistical analysis plans built for FDA and EMA oncology submissions.

Oncology Biostatistics

Bayesian adaptive designs, BOIN dose optimization, and seamless Phase I/II trials for cancer therapeutics. From solid tumor dose escalation to hematologic malignancy registration studies. Statistical analysis plans built for FDA and EMA oncology submissions.

Oncology Biostatistics

Bayesian adaptive designs, BOIN dose optimization, and seamless Phase I/II trials for cancer therapeutics. From solid tumor dose escalation to hematologic malignancy registration studies. Statistical analysis plans built for FDA and EMA oncology submissions.

Evidence Synthesis

Systematic literature reviews, network meta analyses, and synthetic control arms for oncology drugs. Designed for NICE cancer technology appraisals, ICER value assessments, EU Joint Clinical Assessment, and global HTA submissions.

Evidence Synthesis

Systematic literature reviews, network meta analyses, and synthetic control arms for oncology drugs. Designed for NICE cancer technology appraisals, ICER value assessments, EU Joint Clinical Assessment, and global HTA submissions.

Fractional Biometrics

Embedded statistical leadership for your cancer drug program. We join FDA Type B meetings, oversee your CRO, serve on data monitoring committees, and defend your clinical development strategy to investors and the Oncology Center of Excellence.

Fractional Biometrics

Embedded statistical leadership for your cancer drug program. We join FDA Type B meetings, oversee your CRO, serve on data monitoring committees, and defend your clinical development strategy to investors and the Oncology Center of Excellence.

Our Expertise & Solutions

Oncology Biostatistics

Oncology Biostatistics

Oncology Biostatistics

Evidence Synthesis

Evidence Synthesis

Fractional Biometrics

Fractional Biometrics

Your cancer trial data deserves more than a generalist.

Your cancer trial data deserves more than a generalist.

Your cancer trial data deserves more than a generalist.